CFO transition

Neuronetics, Inc. CFO transition: Nir Naor to succeed W. Andrew Macan

Neuronetics, Inc. reported in a Form 8-K filed July 20, 2026 that Nir Naor will succeed W. Andrew Macan as Executive Vice President, Chief Financial Officer, and Treasurer, effective July 23, 2026.

In the filing's words

On July 9, 2026, the Board appointed Nir Naor as the Company’s Executive Vice President, Chief Financial Officer, and Treasurer with an effective date on or about July 23, 2026.

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

CompanyNeuronetics, Inc. (STIM)
EventTransition
IncomingNir Naor
OutgoingW. Andrew Macan
Title in the filingExecutive Vice President, Chief Financial Officer, and Treasurer
EffectiveJuly 23, 2026
8-K filedJuly 20, 2026
Internal promotionNo
Prior role (per filing)Chief Financial Officer, Axogen, Inc. (NASDAQ: AXGN)
SEC CIK0001227636

Neuronetics, Inc. reported this change in a Form 8-K, Item 5.02, filed July 20, 2026. The filing's own words are quoted above.

Also filed in July 2026

Other CFO moves on the record that month. All moves.

3 months ago· 2026-07-31DepartureARAI

Arrive AI Inc. discloses CFO departure: Todd Pepmeier

3 months ago· 2026-07-31TransitionMAYS

J.W. Mays, Inc. CFO transition: Kevin Guptar to succeed Ward Lyke, Jr.

3 months ago· 2026-07-31AppointmentQNCX

Quince Therapeutics, Inc. appoints John Militello as CFO

3 months ago· 2026-07-31AppointmentGCAN

The Greater Cannabis Company, Inc. appoints Michelle Cervantes Vivanco as CFO

3 months ago· 2026-07-31DepartureTG

Tredegar Corporation discloses CFO departure: Frasier W. Brickhouse, II

3 months ago· 2026-07-30DepartureCBT

Cabot Corporation discloses CFO departure: Erica McLaughlin

Sources

  • sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about Nir Naor? Send a correction with the primary source.